A STUDY OF THE VALUE OF HALOPERIDOL IN THE MANAGEMENT AND TREATMENT OF SCHIZOPHRENIC AND MANIC PATIENTS.
D001714:Bipolar Disorder; D004358:Drug Therapy; D006220:Haloperidol; D001523:Mental Disorders; D010276:Parasympatholytics; D011618:Psychotic Disorders; D012559:Schizophrenia; D014116:Toxicology; D014268:Trifluoperazine
D010276:Parasympatholytics; D014268:Trifluoperazine; D006220:Haloperidol
DRUG THERAPY; HALOPERIDOL; PARASYMPATHOLYTICS; PSYCHOSES, MANIC-DEPRESSIVE; SCHIZOPHRENIA; TOXICOLOGIC REPORT; TRIFLUOPERAZINE